Home › Markets › Health Care › GLAS

Glass House Brands Inc. Subordinate Voting Shares (GLAS)

GLAS trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$3.85
-5.64% on the day
Market cap
$338.8M
Small cap
Revenue · 2025
$182.0M
-9.4% on 2024
Net income · 2025
-$29.7M
-16.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerGLAS on NYSE
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryNot reported by the screener
IPO yearNot reported by the screener
SEC CIK0001848731
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inA1

Financials · 2025

LineValue
Revenue$182.0M
Net income-$29.7M
Operating income-$16.5M
Net margin-16.3%
Operating margin-9.1%
Revenue growth-9.4%
CashNot in SEC XBRL data
Total assets$318.6M
P/E (computed)Net income was not positive
P/S (computed)1.9×

Key SEC documents

DocumentFormFiled
Latest annual report40-F2026-03-24
Latest quarterly / interim
FORM 6-K
6-K2026-10-09

Source: SEC EDGAR submissions feed, 192 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-28.7%
1 month-54.5%
3 months-64.6%
Year to date-58.6%
1 year-58.0%
From 52-week high-73.1%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
OBIOOrchestra BioMed Holdings Inc.$5.72-3.21%$343.8M
CGCCanopy Growth Corporation Common Shares$0.7625+0.66%$322.6M
USNAUSANA Health Sciences Inc.$15.46+3.41%$285.6M
SNDLSNDL Inc. Common Shares$1.16-0.85%$285.5M
ACBAurora Cannabis Inc. Common Shares$4.29-1.38%$265.8M
TLRYTilray Brands Inc. Common Stock$3.27-2.68%$483.3M
NAGENiagen Bioscience Inc.$2.58-1.90%$204.1M
MDWDMediWound Ltd.$12.22-2.71%$157.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier